No Data
No Data
Ocugen Inc. Stock Rises Thursday, Outperforms Market
Ocugen Inc. Stock Sheds 6.5%, Underperforms Market
Is Ocugen Inc. (NASDAQ:OCGN) the Best Penny Stock to Invest in Under $1?
Ocugen Inc. Stock Advances 4.1%, Outperforms Market
Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.
① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.
Ocugen Management to Meet With Maxim